Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation

Cancer Letters

Volumn 267, Issue 1, 2008, Pages 116-124

  Taylor, James T ^a   Huang, Luping ^a   Pottle, Jonathan E ^a   Liu, Kai ^a   Yang, Yali ^a   Zeng, Xiangbin ^a   Keyser, Brian M ^a   Agrawal, Krishna C ^a   Hansen, J Bondo ^b   Li, Ming ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Breast cancer; NNC 55 0396; Proliferation; siRNA; T type calcium channel

Indexed keywords

2 [2 [N [(3 BENZOIMIDAZOL 2 YL)PROPYL] N METHYLAMINO]ETHYL] 6 FLUORO 1,2,3,4 TETRAHYDRO 1 ISOPROPYL 2 NAPHTYL VALEROATE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; MIBEFRADIL;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOSTASIS; DRUG INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BENZIMIDAZOLES; BREAST; BREAST NEOPLASMS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELL LINE; CELL PROLIFERATION; HUMANS; RNA, SMALL INTERFERING;

EID: 45849103510     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.032     Document Type: Article

References (37)

1. Ariyoshi H., Okahara K., Sakon M., Kambayashi J., Kawashima S., Kawasaki T., and Monden M. Possible involvement of m-calpain in vascular smooth muscle cell proliferation. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 493-498
2. (2+) oscillation and cell proliferation via CCK(B)/gastrin receptor. Biochem. Biophys. Acta 1452 (1999) 243-253
3. Parhamifar L., Jeppsson B., and Sjolander A. Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells. Carcinogenesis 26 (2005) 1988-1998
4. Li X., Zhang S., and Safe S. Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds. J. Steroid Biochem. Mol. Biol. 98 (2006) 122-132
5. 2+ signaling, intracellular pH and cell volume in cell proliferation. J. Membr. Biol. 205 (2005) 129-137
6. Kunzelmann K. Ion channels and cancer. J. Membr. Biol. 205 (2005) 159-173
7. Lang F., Foller M., Lang K.S., Lang P.A., Ritter M., Gulbins E., Vereninov A., and Huber S.M. Ion channels in cell proliferation and apoptotic cell death. J. Membr. Biol. 205 (2005) 147-157
8. 2+ channel required for the survival of prostate cancer cells. Cancer Res. 64 (2004) 8365-8373
9. Schwarz E.C., Wissenbach U., Niemeyer B.A., Strauss B., Philipp S.E., Flockerzi V., and Hoth M. TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium 39 (2006) 163-173
10. 2+ channel alpha1-subunits and a novel spliced variant of the alpha1C-subunit in rat ductus arteriosus. Am. J. Physiol. 290 (2006) H1660-H1670
11. 2+ channel inhibition in cultured vascular smooth muscle cells. Hypertens. Res. 28 (2005) 545-552
12. 2+ levels in and the growth of human prostate cancer PC3 cells. Clin. Exp. Pharmacol. Physiol. 2 (2005) 735-741
13. Panner A., Cribbs L.L., Zainelli G.M., Origitano T.C., Singh S., and Wurster R.D. Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 37 (2005) 105-119
14. 2+ currents in cultured newborn rat ventricular myocytes. J. Mol. Cell. Cardiol. 30 (1998) 1095-1103
15. Wang Y.-Q., Gavin B., Zhu C.-B., Yuan W.-Z., Li Y.-Q., and Wu X.-S. Functional analysis of the human T-type calcium channel α1H subunit gene in cellular proliferation. Acta Genetica Sinica 29 (2002) 659-665
16. 2+ channels are involved in high glucose-induced rat neonatal cardiomyocyte proliferation. Pediatr. Res. 57 (2005) 550-556
17. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ. Res. 79 (1996) 14-19
18. Rodman D.M., Reese K., Harral J., Fouty B., Wu S., West J., Hoedt-Miller M., Tada Y., Li K.X., Cool C., Fagan K., and Cribbs L. Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ. Res. 96 (2005) 864-872
19. Villame J., Massicotte J., Jasmin G., and Dumont L. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7. 1 cardiomyopathic hamster. Cardiovasc. Drugs Ther. 15 (2001) 41-48
20. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ. Res. 73 (1993) 777-782
21. Schmitt R., Clozel J.P., Iberg N., and Buhler F.R. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler. Thromb. Vasc. Biol. 8 (1995) 1161-1165
22. Mariot P., Vanoverberghe K., Lalevee N., Rossier M.F., and Prevarskaya N. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J. Biol. Chem. 277 (2002) 10824-10833
23. (2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol. Pharmacol. 62 (2002) 210-219
24. (2+) channel expression in human esophageal carcinomas: a functional role in proliferation. Cell Calcium (2007) Epub May 24
25. Asaga S., Ueda M., Jinno H., Kikuchi K., Itano O., Ikeda T., and Kitajima M. Identification of a new breast cancer-related gene by restriction landmark genomic scanning. Anticancer Res. 26 (2006) 35-42
26. ++ channels. J. Pharmacol. Exp. Ther. 271 (1994) 1483-1488
27. 2+ channels by diphenylbutylpiperidine antipsychotics linked to inhibition of prolactin gene expression. J. Biol. Chem. 265 (1990) 16373-16379
28. Protas L., and Robinson R.B. Mibefradil, an I(Ca,T) blocker effectively blocks I(Ca,L) in rabbit sinus node cells. Eur. J. Pharmacol. 401 (2000) 27-30
29. 2+ currents in pancreatic β-cells. J. Pharmacol. Exp. Ther. 292 (2000) 939-943
30. (+) channel. Biochem. Biophys. Res. Commun. 286 (2001) 499-504
31. Huang L., Keyser B.M., Tagmose T.M., Hansen J.B., Taylor J.T., Zhuang H., Zhang M., Ragsdale D.S., and Li M. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J. Pharmacol. Exp. Ther. 309 (2004) 193-199
32. Galkin B.M., Feig S.A., Patchefsky A.S., Rue J.W., Gamblin Jr. W.J., Gomez D.G., and Marchant L.M. Ultrastructure and microanalysis of "benign" and malignant" breast calcifications. Radiology 124 (1977) 245-249
33. Percival R.C., Yates A.J., and Gray R.E. Mechanism of malignant hypercalcemia in carcinoma of the breast. Br. Med. J. Clin. Res. 191 (1985) 776-779
34. Silver I.A., Murrils R.J., and Etherington D.J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteroclasts. Exp. Cell. Res. 175 (1988) 266-276
35. Whitfield J.F. Calcium signals and cancer. Crit. Rev. Oncog. 3 (1992) 55-90
36. Wonderlin W.F., Woodfork K.A., and Strobl J.S. Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J. Cell. Physiol. 165 (1995) 177-185
37. Crunelli V., Toth T.I., Cope D.W., Blethyn K.L., and Hughes S.W. The 'window' T-type calcium current in brain dynamics of different behavioural states. J. Physiol. 562 (2005) 121-129